Psychiatry goes psychedelic

Nat Med. 2021 Dec;27(12):2056-2057. doi: 10.1038/s41591-021-01609-x.
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Depression / drug therapy*
  • Escitalopram / therapeutic use*
  • Hallucinogens / therapeutic use*
  • Humans
  • Psilocybin / therapeutic use*
  • Psychiatry*
  • Randomized Controlled Trials as Topic
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Escitalopram
  • Hallucinogens
  • Psilocybin
  • Selective Serotonin Reuptake Inhibitors